Search results
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
The Sacramento Bee· 2 days agoModerna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 4 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 7 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC’s ‘Final Trades’ - Oracle (NYSE:ORCL)
Benzinga· 2 days agoOn CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 1 day agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Moderna scores European victory over Pfizer and BioNTech in mRNA patent battle
Endpoints News· 7 days agoThe European Patent Office on Thursday handed a win to Moderna in a long-running patent battle with...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
The Motley Fool via AOL· 2 hours ago(For example, it helps drug companies manage their clinical trials.) Its myriad customers include Lilly, Merck, Pfizer, and Moderna. In its fourth quarter, growth stock Veeva ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 4 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Sunny Side Up in UK / West End at Soho Theatre 2024
Broadway World· 50 minutes agoComplete Information About Sunny Side Up in UK / West End at Soho Theatre. A love letter to growing up in a particular place, at a particular time with a...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...